Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DE8S2F
|
|||
| Drug Name |
DFP-14927
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1 | [1] | |
| Company |
Delta-Fly Pharma
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | DNA-dependent DNA polymerase (DPOL) | Target Info | Inhibitor | [2] |
| Human Deoxyribonucleic acid (hDNA) | Target Info | Inhibitor | [2] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03943004) Trial of DFP-14927 in Advanced Solid Tumors. U.S. National Institutes of Health. | |||
| REF 2 | National Cancer Institute Drug Dictionary (drug name DFP14927). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.